Under the terms of the deal, 23andMe will acquire Lemonaid for $100 million in cash and $300 million in common stock. The transaction is expected to close by the end of the year.
from Section Page News - Modern Healthcare https://ift.tt/3CajvN6
Friday, October 22, 2021
23andMe to acquire telemedicine platform company Lemonaid Health for $400M in cash, stock23andMe to acquire telemedicine platform company Lemonaid Health for $400M in cash, stock23andMe to acquire telemedicine platform company Lemonaid Health for $400M in cash, stock
23andMe to acquire telemedicine platform company Lemonaid Health for $400M in cash, stock
from Section Page News - Modern Healthcare https://ift.tt/3CajvN6
from Section Page News - Modern Healthcare https://ift.tt/3CajvN6
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment